Interestingly, we found no statistically significant differences in the pathologic characteristics between MBCs in BRCA1/2 mutation carriers and those in the general population, with the exception of histologic grade. This evidence concerns the gene BRCA1 and maternal uniparental disomy of chromosome 20.